Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
387.00    2.00 (0.52%)
Bid:
387.50
Ask:
389.50
Spread: 2.00 (0.516%)
Market Cap: £1.75b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Acquisition

19 Dec 2007 14:25

HG Capital Trust PLC19 December 2007 The following is the text of a press release issued by HgCapital, which managesthe investment portfolio of HgCapital Trust plc alongside those of otherinstitutional clients. The Trust, which is a listed investment trust givinginvestors the opportunity to participate in all of HgCapital's investments, willinvest approximately €16.7million (£12m) in Casa Reha. HgCapital acquires Casa Reha from Advent International London, 19th December 2007: HgCapital, the European sector-focused privateequity investor, has acquired Casa Reha, one of the leading German privatenursing home groups. The transaction is subject to regulatory approval. Thecompany has been acquired from Advent International and management, both ofwhich are re-investing in the business. The value of the transaction wasundisclosed. Casa Reha, founded in 1995 by Covenant Care International is headquartered inOberursel, Germany. The first nursing home was opened in 1996. Today, Casa Rehais the country's fifth largest nursing home operator, with a nationwideportfolio of 48 homes providing around 7,000 beds. Contacts: HgCapitalPhilipp Schwalber Tel: +44 (0)20 7089 7888 Hering-Schuppener (German Press)Georg Jakobs/Dennis Bader Tel: +49 (69) 92187476 Maitland (UK Press)Peter Ogden Tel: +44 (0)20 7379 5151 Advent InternationalClaudia Werth Tel: +49 (69) 92037 114 About HgCapitalHgCapital is a private-equity investor in the European mid-market. We focus oninvestments with an enterprise value in the range of €75-750 million. Ourbusiness model combines sector specialisation with dedicated, pro-active supportto our portfolio companies as well as the corresponding management expertiseacross all phases of the investment process. HgCapital manages more than €2.7billion for some of the world's leading institutional and private investors. Ourgoal is to achieve outstanding results for our investors, management team andintermediaries. Further information on HgCapital can be found atwww.hgcapital.com. HgCapital's recent transactions in the healthcare sector include: • May 2007: sale of DocMorris to Celesio • July 2006: sale of Castlebeck to Castle Holdings Limited for £255m • June 2006: IPO of ClinPhone - market capitalisation of £94 million • June 2006: Sale of Pharma Bio-Research BV (PBR) to PRA International for £58 million • April 2006: £322 million MBO of Paragon Healthcare • September 2005: Sale of Tunstall for £220 million About Advent InternationalFounded in 1984, Advent International is one of the world's leading globalprivate equity firms, with offices in 15 countries on four continents. A drivingforce in international private equity for more than two decades, Advent hasbuilt an unparalleled global platform of over 100 investment professionalsacross Western and Central Europe, North America, Latin America and Asia. Thefirm focuses on cross-border, strategic restructuring and growth opportunitiesin five core sectors, employing a highly focused ownership approach to driveearnings improvements in portfolio companies. Since inception, Advent has raised£6 billion in private equity capital and completed more than 200 buyout andprivate equity transactions valued at over £15 billion in 35 countries. For moreinformation, visit www.adventinternational.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th May 202110:40 amRNSBlock listing Interim Review
12th May 20214:00 pmRNSQ1 Report to 31 March 2021
11th May 20216:04 pmRNSResult of AGM
5th May 20217:05 amRNSAnnual General Meeting 2021
4th May 20217:00 amRNSHg sells Eidosmedia to CAPZA
16th Apr 20217:00 amRNSHg invests in AUVESY
15th Apr 20214:00 pmRNSDirector/PDMR Shareholding
13th Apr 20212:07 pmRNSDirector/PDMR Shareholding
13th Apr 20217:00 amRNSHg invests in Dext
1st Apr 202110:18 amRNSTotal Voting Rights
1st Apr 20217:00 amRNSEdison issues review on HgCapital Trust (HGT)
31st Mar 20215:26 pmRNSIssue of Equity
24th Mar 20215:10 pmRNSIssue of Equity
24th Mar 20213:15 pmRNSTrackunit attracts strategic investment from Hg
24th Mar 20217:00 amRNSMitratech Announces Strategic Investment from OTPP
24th Mar 20217:00 amRNSHg sells Trace One to Symphony Technology Group
18th Mar 20215:30 pmRNSIssue of Equity
17th Mar 20214:56 pmRNSIssue of Equity
16th Mar 20215:25 pmRNSIssue of Equity
15th Mar 20215:46 pmRNSIssue of Equity
15th Mar 20217:00 amRNSAnnual Financial Report
15th Mar 20217:00 amRNSHgCapital Trust Annual Results 2020
18th Feb 20213:49 pmRNSHolding(s) in Company
18th Jan 20219:40 amRNSHg invests in TeamSystem
6th Jan 202111:00 amRNSHg invests in Prophix
4th Jan 20215:08 pmRNSTotal Voting Rights
31st Dec 20201:03 pmRNSIssue of Equity
30th Dec 20205:19 pmRNSIssue of Equity
29th Dec 20205:13 pmRNSIssue of Equity
24th Dec 20201:20 pmRNSIssue of Equity
23rd Dec 20205:23 pmRNSIssue of Equity
22nd Dec 202012:43 pmRNSEdison issues review on HgCapital Trust (HGT)
21st Dec 20204:40 pmRNSBlock listing six monthly return
18th Dec 20207:00 amRNSHg invests in Geomatikk Group
17th Dec 20205:30 pmRNSIssue of Equity
17th Dec 20203:49 pmRNSHolding(s) in Company
7th Dec 20205:36 pmRNSIssue of Equity
4th Dec 20205:28 pmRNSIssue of Equity
3rd Dec 20205:22 pmRNSIssue of Equity
3rd Dec 20207:12 amRNSHg announces an investment in Benevity
2nd Dec 20205:23 pmRNSIssue of Equity
30th Nov 20201:05 pmRNSTotal Voting Rights
24th Nov 20205:30 pmRNSIssue of Equity
23rd Nov 20205:31 pmRNSIssue of Equity
20th Nov 20205:27 pmRNSIssue of Equity
19th Nov 20205:15 pmRNSIssue of Equity
19th Nov 20207:00 amRNSHg invests in The Septeo Group
18th Nov 20206:05 pmRNSIssue of Equity
16th Nov 20205:51 pmRNSIssue of Equity
13th Nov 20205:32 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.